The importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasia

Int J Cardiol. 2022 Apr 15:353:53. doi: 10.1016/j.ijcard.2022.01.025. Epub 2022 Jan 17.

¹ Canakkale Onsekiz Mart University Faculty of Medicine, Department of Cardiology, Canakkale, Turkey. Electronic address: ercanaksit@comu.edu.tr.
² Canakkale Onsekiz Mart University Faculty of Medicine, Department of Cardiology, Canakkale, Turkey.
³ Trakya University Faculty of Medicine, Department of Cardiology, Edirne, Turkey.
⁴ Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Department of Cardiology, İstanbul, Turkey.
⁵ University of Health Sciences, Basaksehir Cam ve Sakura City Hospital, Department of Cardiology, İstanbul, Turkey.

No abstract available

Keywords: Anti-fibrotic drugs; Arrhythmogenic cardiomyopathy; Cardiac fibrosis; Remodeling.

Publication types